ReviewRSC advances2026
2-Aminooxazoles and 2-aminothiazoles: green regioselective synthesis and bioactivity.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
2-Aminooxazole and 2-aminothiazole are heterocyclic compounds that can be developed to be therapeutically significant in medicinal chemistry as they are associated with a myriad of biologically important multicentric activities such as anticancer, anti-viral, anti-bacterial, anti-fungal, and enzyme inhibition. Chemically, they have been reported to target critical enzymes such as CDKs, aurora kinases, DHPS, and proteases. However, traditional routes to construct heterocyclic compounds are fraught with difficulties, such as poor regioselective control, producing C-4/C-5 regioisomeric mixtures, poor atom economy, laborious purifications, and a substantial waste of solvents. Recently developed green synthetic approaches, such as microwave-assisted synthesis, ultrasound activation, multicomponent reactions, nanocatalysis, and newer techniques that employ syntheses in aqueous media and in a solvent-free manner, have attempted to address these issues. These methods provide better regioselectivity, better reaction efficiencies, and better yields. In the context of synthetic medicinal chemistry, the green approaches enhance the safety and convenience of laboratory operations by decreasing the need for hazardous solvents. However, the absence of the
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.